Patients’ experience with chimeric antigen receptor T-cell therapy for DLBCL in China: a qualitative study

PURPOSE: The experiences of patients with diffuse large B-cell lymphoma (DLBCL) treated with chimeric antigen receptor (CAR) T-cell therapy have received little attention. This study aimed to explore the treatment experiences of patients with relapsed or refractory (R/R) B-cell lymphoma during CAR T...

Descripción completa

Detalles Bibliográficos
Autores principales: Mao, Yiwen, Huang, Lihong, Ruan, Haitao, Guo, Yue, Ni, Sha, Ling, Yuying
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2023
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10131511/
https://www.ncbi.nlm.nih.gov/pubmed/37099077
http://dx.doi.org/10.1007/s00520-023-07763-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10131511/
https://www.ncbi.nlm.nih.gov/pubmed/37099077
http://dx.doi.org/10.1007/s00520-023-07763-x

Ejemplares similares